Home

Cover Story

Table of Contents

E-Newsletter

Article Archive

Editorial Calendar

Datebook

Writers' Guidelines

Orgs/Links

Opinion Polls

Reprints

Forum

Search

Oct. 22 - Senorx Announces 510(k) Clearance for its Breat Biopsy Ultrasound System

SenoRx, Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its SenoSonix System, an integration of its EnCor breast biopsy system with a state-of-the-art ultrasound imaging system.

The device incorporates SenoRx’s proprietary EnCor vacuum-assisted biopsy technologies with an ultrasound system developed and sold by Ultrasonix Medical Corporation of Canada. SenoRx and Ultrasonix have enjoyed a close working relationship, jointly developing the technology that facilitates the integration of the two products. The product will be branded SenoSonix and marketed as SenoSonix with EnCor Inside.

Source: SenoRx

(View the Daily News Archive)

Survey

Is teleradiology more of a help or a threat to your facility? Help     Threat     We do not use teleradiology in our facility.     View results